Pratap Neelakantan, David Marin, Mike Laffan, John Goldman, Jane Apperley, Dragana Milojkovic. Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy. haematol [Internet]. 2012Sep.5 [cited 2024Apr.20];97(9):1444-. Available from: https://haematologica.org/article/view/6417